Gastric Cancer Stem Cells

There may be a huge worldwide health problem with gastric cancer. It is the third most common cause of cancer-related death worldwide and the fifth most common cancer. Because of tumor relapse and metastasis, the prognosis overall is still poor despite advancements in treatment. To improve clinical outcomes in stomach cancer, novel therapeutic techniques are urgently needed. To explain the high rate of relapse and subsequent resistance of cancer to systemic therapy, the cancer somatic cell (CSC) model has been put forth. The discovery of CSCs in a variety of solid tumors, such as gastric cancer, has important clinical ramifications because focusing on this population may be crucial for halting tumor growth and recurrence.


    Related Conference of Gastric Cancer Stem Cells

    April 17-18, 2024

    14th International Conference on Chemistry Meeting

    Paris, France
    June 25-26, 2024

    13th World Congress on Chromatography

    Toronto, Canada
    August 22-23, 2024

    16th International Conference on Clinical Chemistry

    Berlin, Germany

    Gastric Cancer Stem Cells Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in